New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The home shipments — which will be fulfilled by CenterWell Pharmacy — include Wegovy injections of 0.25 mg, 0.5 mg, 1 mg, 1.7 ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Novo Nordisk, the manufacturer of Weggovy, is growing its offerings by creating NovoCare Pharmacy, a direct-to-patient (DTP) ...

Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also ...

Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic ... in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL doses in a single-dose pen.

Last week, the Food and Drug Administration removed semaglutide, the active ingredient in Ozempic, from its shortage list. The FDA allows for the sale of compounded versions of drugs on its ...

The need to be thinner has fuelled the sale of weight-loss drugs such as Ozempic and Wegovy across the globe ... Their many efforts culminated when they identified what they called exendin-4, which ...

As a registered dietitian, I've noticed a growing trend in my practice: more and more clients are being prescribed GLP-1 medications like Ozempic. Whether you're just starting your journey with these ...

MONDAY, Feb. 24, 2025 (HealthDay News) -- People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve ...